Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pulmatrix (PULM) EBITDA (2016 - 2025)

Pulmatrix's EBITDA history spans 13 years, with the latest figure at -$908000.0 for Q4 2025.

  • For Q4 2025, EBITDA rose 53.48% year-over-year to -$908000.0; the TTM value through Dec 2025 reached -$5.2 million, up 47.06%, while the annual FY2025 figure was -$5.2 million, 47.06% up from the prior year.
  • EBITDA for Q4 2025 was -$908000.0 at Pulmatrix, down from -$866000.0 in the prior quarter.
  • Across five years, EBITDA topped out at $747000.0 in Q1 2024 and bottomed at -$8.2 million in Q3 2021.
  • The 5-year median for EBITDA is -$4.0 million (2023), against an average of -$3.4 million.
  • The largest annual shift saw EBITDA crashed 541.35% in 2021 before it soared 116.29% in 2024.
  • A 5-year view of EBITDA shows it stood at -$4.0 million in 2021, then dropped by 6.98% to -$4.3 million in 2022, then surged by 48.55% to -$2.2 million in 2023, then rose by 12.27% to -$2.0 million in 2024, then soared by 53.48% to -$908000.0 in 2025.
  • Per Business Quant, the three most recent readings for PULM's EBITDA are -$908000.0 (Q4 2025), -$866000.0 (Q3 2025), and -$1.5 million (Q2 2025).